Under the 11-page 'roadmap' outlined Thursday, the goal is for animal testing to become 'the exception rather than the norm' ...

Bristol Myers Squibb’s combined immunotherapies Opdivo and Yervoy won approval this week as a first-line treatment for ...

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Argenx's Vyvgart Hytrulo gets FDA approval for self-injection syringe, Opthea cuts 65% staff after trial failures, Protagonist reports psoriasis success, Pfizer cuts jobs, Keros reviews options ...

CDMOs fear that FDA site inspections might slow down due to the mass staffing cuts at the federal health agencies.

Trump signals imminent pharma tariffs, with experts including Mollie Sitkowski of Faegre Drinker suggesting 25% levy possible ...

Scientists develop STITCHR, a retrotransposon-based gene editing tool, by Omar Abudayyeh (Mass General Brigham) and Jonathan ...

After 17 years at Genentech, Ira Mellman is joining the Parker Institute for Cancer Immunotherapy as president of research.

Alzheon’s con­tro­ver­sial, decade-long bet that a failed Alzheimer’s drug could of­fer big­ger ben­e­fits to a sub­set of pa­tients at the high­est risk for the dis­ease … ...